Nathan Beaumont
Papers
2
Total Citations
17
H-Index
2
About
Nathan Beaumont is a biomedical researcher specializing in preclinical imaging and translational oncology, with a focus on noninvasive techniques for evaluating disease progression in murine models. His major contributions center on validating advanced imaging modalities—such as combined ultrasound and bioluminescence systems—against gold-standard magnetic resonance imaging (MRI) to improve the accuracy of tumor assessment in orthotopic pancreatic cancer models. This work, published in 2022 and cited 12 times, addresses the critical need for more clinically relevant preclinical evaluations by enabling longitudinal monitoring of deep-tissue tumors. Beaumont has also advanced the study of polycystic kidney disease (PKD) by comparing robotic 3D ultrasound with MRI for measuring total kidney volume, a key biomarker for staging disease severity. His 2020 paper, with 5 citations, highlights the potential of ultrasound as a more accessible alternative to MRI in rodent models. Through these efforts, Beaumont demonstrates a commitment to refining noninvasive imaging techniques that bridge preclinical research and clinical translation, offering tools that enhance the reliability of therapeutic efficacy studies. His work is particularly valuable for researchers seeking to improve the reproducibility and translational relevance of animal models in cancer and renal disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2